Murata Manufacturing Co., Ltd.

Mitsubishi Kasei Corporation

Other

Kimberly-clark Worldwide, Inc.

Mitsubishi Chemical Corporation

Sanyo Chemical Industries, Ltd.

Mitsubishi Corporation

Kazuhiro Takahashi

Jun Kondo

Naomi Kitamura

Rie Matsui

Hidechika Okada

Noriko Okada

Yoichi Nagami

Hisao Takizawa

Vasily Aramovich Topolkaraev

Dave Allen Soerens

Mark Michael Mleziva

Neil T Scholl

WanDuk Lee

Theodore T Tower

Yutaka Teranishi

Yuriy Galabura

Karen Goeders

Keiji Miyazawa

Austin N Pickett

Shigetada Nakanishi

Daiji Naka

Lori A Eslinger

Hirohito Tsubouchi

Akiko Mori

Yoshiko Yoshiyama

Masato Kurokawa

Yuji Hiraki

Fujio Suzuki

Yasushi Daikuhara

Yusuke Ueda

Junko Suzuki

Atsuko Kohara

Ei Yamada

Takehisa Ishii

Megumi Tomioka

Tatsurou Shibui

Michiru Kamizono

Tetsurou Ashida

A filter element is mounted on a module substrate. The filter element includes a ground terminal and a pair of signal terminals. The module substrate includes a ground plane, a ground land, and an inductance adjusting line that connects the ground land to the ground plane. The ground terminal of the filter element is connected to the ground land of the module substrate. The inductance adjusting line includes an in-plane extending portion that extends in an in-plane direction of the module substrate.

Filter module

Superabsorbent particles have a median size of from about 50 to about 2,000 micrometers and contain a porous network that includes a plurality of nanopores having an average cross-sectional dimension of from about 10 to about 500 nanometers, wherein the superabsorbent particles exhibit a Vortex Time of about 80 seconds or less and a free swell gel bed permeability (GBP) of 5 darcys or more, of 10 darcys or more, of 20 darcys or more, of 30 darcys or more, of 60 darcys or more, or of 90 darcys or more. A method for forming such superabsorbent particles includes forming a composition that contains a superabsorbent polymer and a solvent system; contacting the composition with a non-solvent system to initiate formation of the porous network through phase inversion; removing non-solvent from the composition; and surface crosslinking the superabsorbent particles.

Nanoporous superabsorbent particles

A filter device is mounted on a module substrate and is shielded by a shield member. The filter device has first and second side surfaces opposed to each other. A ground terminal and signal terminals are formed on a bottom surface of the filter device. The shield member includes side wall portions facing the first and second side surfaces. The filter device includes plural LC parallel resonance circuits therein. The inductors of the LC parallel resonance circuits are arranged in parallel with the first side surface and the bottom surface. Each inductor extends upward from its end portion electrically connected to the ground terminal, extends from the first side surface toward the second side surface, and then extends toward the bottom surface. The gap between the first side surface and the corresponding side wall portion is smaller than that between the second side surface and the corresponding side wall portion.

A high-frequency circuit includes a transmission circuit that transmits a high-frequency signal, a reception circuit that receives a high-frequency signal, and a multiplexer that separates a reception path and a transmission path for high-frequency signals. In the reception circuit, a filter circuit in which a first frequency response and a second frequency response different from the first frequency response can be switched in accordance with a jamming wave for a high-frequency signal to be received is provided in the reception path for a high-frequency signal.

High-frequency signal transmission-reception circuit

A carrier for cell culture is provided which improves the cell proliferativity in serum-free culture and which is free from risk from infection factor contamination. The gist of the features of the present invention is to be formed of a crosslinked poly(meth)acrylic acid (salt) particle (A) and an artificial polypeptide (P) having at least one cell-adhesive minimal amino acid sequence (X) in one molecule and to have a water retention value of from 2 to 50 g/g. The (A) is preferably a particle produced by reversed phase suspension polymerization of an aqueous monomer solution containing (meth)acrylic acid and/or an alkali metal salt of (meth)acrylic acid. The (P) preferably has at least one auxiliary amino acid sequence (Y) in one molecule of the (P). The (X) is preferably an Arg Gly Asp sequence.

Cell culture carrier comprising poly(meth)acrylic (salt) particle and artificial polypeptide

A novel human chondromodulin-I protein having a molecular weight of about 26,000 dalton on SDS-PAGE and capable of stimulating the growth of chondrocytes with or without FGF, promoting the differential potency of these cells, and inhibiting the growth of vascular endothelial cells, a DNA encoding this protein, expression vector containing the DNA, a transformant capable of producing recombinant chondromodulin-I protein, a process for producing chondromodulin-I protein by culturing the transformant and a pharmaceutical composition containing chondromodulin-I protein as an active ingredient.

Human chondromodulin-I protein

The present invention provides a glycoprotein derived from human cell membrane, which has a molecular weight of 20 to 25 Kd as estimated by SDS polyacrylamide gel electrophoresis, and contains N-glycoside type carbohydrate chain and phosphatidylinositol, and possesses an inhibitory activity to complement-mediated cell membrane damage. The present invention further provides a gene coding for the glycoprotein, and a method for the production of the glycoprotein and the gene therefor.

Glycoprotein and gene coding therefor

According to the present invention, there are provided hepatic parenchymal cell growth factor obtained by recombinant DNA technology, a gene coding for the factor, an expression vector capable of expressing the gene, a cell, in particular animal cell, transformed with the expression vector, and a process for producing the hepatic parenchymal cell growth factor.

Hepatic parenchymal cell growth factor gene encoding the same, process

Provided herein are a DNA fragment which contains a base sequence coding for a non-A non-B hepatitis-specific antigenic protein occurring in cells of the liver affected with non-A non-B hepatitis, an expression vector in which said DNA fragment is inserted into a cloning site present downstream from a promoter thereof, a transformant obtained by introducing said expression vector into a host, and a process for producing said antigenic protein which comprises providing said expression vector, transforming a host with said expression vector, culturing the transforming host and collecting the protein produced therein.

DNA fragments coding for antigens specific to non-A non-B hepatitis,

Growing community of inventors

Kyoto, Japan

Kazuhiro Takahashi